Literature DB >> 21394750

Identifying optimal risk windows for self-controlled case series studies of vaccine safety.

Stanley Xu1, Lijing Zhang, Jennifer C Nelson, Chan Zeng, John Mullooly, David McClure, Jason Glanz.   

Abstract

In vaccine safety studies, subjects are considered at increased risk for adverse events for a period of time after vaccination known as risk window. To our knowledge, risk windows for vaccine safety studies have tended to be pre-defined and not to use information from the current study. Inaccurate specification of the risk window can result in either including the true control period in the risk window or including some of the risk window in the control period, which can introduce bias. We propose a data-based approach for identifying the optimal risk windows for self-controlled case series studies of vaccine safety. The approach involves fitting conditional Poisson regression models to obtain incidence rate ratio estimates for different risk window lengths. For a specified risk window length (L), the average time at risk, T(L), is calculated. When the specified risk window is shorter than the true, the incidence rate ratio decreases with 1/T(L) increasing but there is no explicit relationship. When the specified risk window is longer than the true, the incidence rate ratio increases linearly with 1/T(L) increasing. Theoretically, the risk window with the maximum incidence ratio is the optimal risk window. Because of sparse data problem, we recommend using both the maximum incidence rate ratio and the linear relationship when the specified risk window is longer than the true to identify the optimal risk windows. Both simulation studies and vaccine safety data applications show that our proposed approach is effective in identifying medium and long-risk windows.
Copyright © 2010 John Wiley & Sons, Ltd.

Mesh:

Substances:

Year:  2010        PMID: 21394750     DOI: 10.1002/sim.4125

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  6 in total

1.  Bias from outcome misclassification in immunization schedule safety research.

Authors:  Sophia R Newcomer; Martin Kulldorff; Stan Xu; Matthew F Daley; Bruce Fireman; Edwin Lewis; Jason M Glanz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-01-02       Impact factor: 2.890

2.  Bias and estimation under misspecification of the risk period in self-controlled case series studies.

Authors:  Luis Fernando Campos; Damla Şentürk; Yanjun Chen; Danh V Nguyen
Journal:  Stat (Int Stat Inst)       Date:  2017-10-20

3.  Analyzing self-controlled case series data when case confirmation rates are estimated from an internal validation sample.

Authors:  Stanley Xu; Christina L Clarke; Sophia R Newcomer; Matthew F Daley; Jason M Glanz
Journal:  Biom J       Date:  2018-05-16       Impact factor: 2.207

4.  A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design.

Authors:  Stanley Xu; Simon J Hambidge; David L McClure; Matthew F Daley; Jason M Glanz
Journal:  Stat Med       Date:  2013-01-10       Impact factor: 2.373

Review 5.  Case-only designs in pharmacoepidemiology: a systematic review.

Authors:  Sandra Nordmann; Lucie Biard; Philippe Ravaud; Marina Esposito-Farèse; Florence Tubach
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

6.  Use of Fixed Effects Models to Analyze Self-Controlled Case Series Data in Vaccine Safety Studies.

Authors:  Stanley Xu; Chan Zeng; Sophia Newcomer; Jennifer Nelson; Jason Glanz
Journal:  J Biom Biostat       Date:  2012-04-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.